ASCEND BY NTHRYS
Research Abroad Products

Molecular Medicine Project Topics

Browse all focused areas across all project categories under this field.

Showing 157–168 of 200 project topics
Neuroinflammation Molecular Monitoring Dashboard for Clinical Trials
Specialized analytics platform that tracks CSF and blood biomarkers of neuroinflammation (cytokines, phosphorylated tau, amyloid-beta) in real-time during clinical trials for MS, neurodegeneration, and neuroimmune disorders. Provides recurring revenue through licensing to CROs, pharmaceutical sponsors, and specialized neurology research centers managing phase II-III studies.
Molecular Medicine Neurology Analytics Platforms Click to view more details →
Connectome Analysis Software for Neurosurgical Planning and Risk Assessment
Commercial tool that reconstructs and visualizes neural connectivity networks from diffusion MRI data to predict neurological deficits and optimize surgical approaches in brain tumor and epilepsy cases. Captures value through enterprise licensing to neurosurgery departments, neurointerventional centers, and hospital system OR management platforms.
Molecular Medicine Neurology Analytics Platforms Click to view more details →
Multi-Modal Brain Activity Integration Platform for Neurotech Companies
Technical platform that fuses data from fMRI, EEG, fNIRS, and electrophysiology recordings to create unified brain activity models for brain-computer interface and neuromodulation device validation. Supports B2B partnerships with neurotech manufacturers and generates licensing revenue from contract research and device development programs.
Molecular Medicine Neurology Analytics Platforms Click to view more details →
Cognitive Decline Prediction Model with Longitudinal Data Analytics Suite
AI-driven platform that analyzes longitudinal neuropsychological testing, neuroimaging, and biomarker data to predict cognitive decline progression and treatment response in aging and dementia populations. Monetizes through SaaS subscriptions to memory care networks, geriatric practices, pharmaceutical development programs, and insurance companies managing cognitive risk stratification.
Molecular Medicine Neurology Analytics Platforms Click to view more details →
AI-Powered Cardiac Drug Target Discovery Platform
A machine learning platform that identifies novel druggable targets in cardiovascular diseases by analyzing genomic, proteomic, and clinical data at scale. Reduces target validation time by 60% and accelerates time-to-IND filing, enabling companies to monetize discoveries faster through licensing and partnerships.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Personalized Cardiovascular Biomarker Testing SaaS Solution
A cloud-based diagnostic platform that predicts individual patient responses to cardiac therapeutics using multimodal biomarker profiling and genetic stratification. Enables pharma companies to segment patient populations, improve clinical trial efficiency, and support companion diagnostic commercialization with recurring subscription revenue.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
High-Throughput Cardiac Safety Screening Technology Suite
An integrated software and hardware system using human iPSC-derived cardiomyocytes to detect arrhythmia and toxicity risks before clinical trials begin. Reduces drug attrition from cardiac safety failures by 40% and shortens preclinical development timelines, driving significant cost savings and risk mitigation.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Molecular Cardiology Data Analytics and Integration Platform
A unified data management and analysis platform that integrates multiomics data, clinical outcomes, and real-world evidence for cardiovascular drug programs. Provides actionable insights for regulatory submissions and enables real-world evidence monetization through data licensing to payers and CROs.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Artificial Intelligence Heart Failure Drug Optimization Engine
An AI-driven software tool that optimizes dosing regimens, drug combinations, and patient stratification strategies for heart failure therapeutics using proprietary algorithms. Increases phase III success rates and enables data-driven label expansions, unlocking additional market revenue and reducing development risk.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Cardiovascular Pharmacogenomics Clinical Decision Support Tool
A physician-facing software platform that provides real-time genotype-phenotype guided treatment recommendations for hypertension, arrhythmias, and thrombotic disorders. Generates revenue through clinical laboratory licensing, EHR integrations, and pharmaceutical manufacturer partnerships for precision medicine initiatives.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Vasculature-on-Chip Screening and Validation Platform
A microphysiological systems platform with integrated sensors that models human vascular biology for endothelial dysfunction and atherosclerosis drug screening. Commercializes through assay kits, instrument sales, and CRO partnerships, enabling companies to de-risk vascular drug candidates early.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →
Regulatory Intelligence Cardiovascular Clinical Trial Optimization
A software-as-a-service platform that aggregates regulatory guidance, real-world evidence, and competitive trial data to optimize cardiac drug development pathways. Reduces regulatory delays, improves approval rates, and accelerates market entry through subscription-based analytics and consulting services.
Molecular Medicine Cardiovascular Drug Dev Click to view more details →